Ha Noi Pharma Joint Stock Co
UUPCOM:DHN17,000.00
VND
+800.00
(+4.94%)
ISIN
VN000000DHN6
Return %
Stock
S&P 500
1Y
-37.73
14.20
3Y
-19.43
81.12
5Y
-51.29
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Tuan Thi Pham
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Ha Noi Vietnam
- Website
- hanoipharma.com.vn
- Similar Companies
- Business
- Ha Noi Pharma Joint Stock Co, trading on the UPCoM exchange under ticker DHN and commercially known as Hapharco, is a Vietnam-based pharmaceutical manufacturing and healthcare distribution company. Founded in 1955 and headquartered in Hanoi, Vietnam, the company specializes in the development, manufacturing, processing, wholesale distribution, retail, and import-export of finished pharmaceuticals, active pharmaceutical ingredients, and medical healthcare supplies. Ha Noi Pharma operates through multiple core business segments encompassing pharmaceutical production; wholesale and hospital supply; retail pharmacy networks; medical equipment and diagnostic trading; and pharmaceutical logistics and warehousing services. The company offers a comprehensive portfolio of products and services, including prescription (ETC) and over-the-counter (OTC) pharmaceutical drugs such as antibiotics, anti-inflammatory medications, analgesics, antipyretics, respiratory remedies, gastrointestinal treatments, and cardiovascular therapies; traditional and herbal medicinal formulations derived from natural botanicals; dietary supplements, vitamins, and functional nutrition products; medical devices, consumables, and diagnostic reagents; contract manufacturing and packaging services compliant with WHO-GMP, GLP, and GSP standards; and specialized pharmaceutical storage, customs clearance, and cold-chain logistics. Ha Noi Pharma serves a broad customer base comprising public and private hospitals, health clinics, commercial pharmacies, and retail consumers primarily across Northern Vietnam and nationwide, alongside exporting selected medicinal products to regional international markets. In recent developments, the company has undertaken strategic initiatives to modernize its manufacturing infrastructure and warehousing facilities to enhance compliance with upgraded GMP standards, expanded its third-party logistics and distribution partnerships with multinational pharmaceutical brands, strengthened its retail and institutional pharmacy supply chains through digital inventory management, and broadened its commercial portfolio with newly registered OTC health wellness supplements and specialized therapeutic formulations.